Utah Medical Products (NASDAQ:UTMD) Stock Price Crosses Above the 200-Day Moving Average of $87.52
The stock price of Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) rose above its 200-day moving average during Tuesday’s trading session. The stock has a 200-day moving average of $87.52 and is trading as low as $91.11. Shares of Utah Medical Products last traded at $90.32, with a volume of 3,271 shares traded in hands.
Utah medical product inventory performance
The company has a 50-day moving average of $87.35 and a 200-day moving average of $87.52. The company has a market capitalization of $327.41 million, a price-earnings ratio of 20.72 and a beta of 0.26.
Utah Medical Products (NASDAQ:UTMD – Get Rating) last released quarterly earnings data on Tuesday, July 26. The medical device supplier reported EPS of $1.12 for the quarter. The company had revenue of $13.43 million for the quarter. Utah Medical Products had a net margin of 31.18% and a return on equity of 14.69%.
Utah Medical Products Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 5. Shareholders of record on Friday, September 16 will receive a dividend of $0.29 per share. This represents a dividend of $1.16 on an annualized basis and a yield of 1.28%. The ex-dividend date is Thursday, September 15. Utah Medical Products’ dividend payout ratio (DPR) is currently 26.61%.
Institutional entries and exits
A number of hedge funds have recently increased or reduced their stakes in the company. Amalgamated Bank acquired a new position in Utah Medical Products stock during Q1 worth approximately $39,000. Acadian Asset Management LLC acquired a new position in Utah Medical Products during the first quarter valued at approximately $40,000. BNP Paribas Arbitrage SA increased its stake in Utah Medical Products by 97.7% in the second quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical device supplier valued at $67,000 after buying 385 additional shares last quarter. Lazard Asset Management LLC increased its position in Utah Medical Products shares by 21.3% during the first quarter. Lazard Asset Management LLC now owns 837 shares of the medical device supplier worth $75,000 after purchasing an additional 147 shares in the last quarter. Finally, MetLife Investment Management LLC increased its stake in Utah Medical Products shares by 57.0% during the 1st quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical device supplier worth $182,000 after buying 737 additional shares in the last quarter. Institutional investors hold 71.44% of the company’s shares.
Utah Medical Products Company Profile
(Get an evaluation)
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.
Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.